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Abstract
Background: There are now several ways to generate fluorescent fusion proteins by randomly
inserting DNA encoding the Green Fluorescent Protein (GFP) into another protein's coding
sequence. These approaches can be used to map regions in a protein that are permissive for GFP
insertion or to create novel biosensors. While remarkably useful, the current insertional strategies
have two major limitations: (1) they only produce one kind, or color, of fluorescent fusion protein
and (2) one half of all GFP insertions within the target coding sequence are in the wrong orientation.
Results: We have overcome these limitations by incorporating two different fluorescent proteins
coding sequences in a single transposon, either in tandem or antiparallel. Our initial tests targeted
two mammalian integral membrane proteins: the voltage sensitive motor, Prestin, and an ER ligand
gated Ca2+ channel (IP3R).
Conclusions: These new designs increase the efficiency of random fusion protein generation in
one of two ways: (1) by creating two different fusion proteins from each insertion or (2) by being
independent of orientation.
Background
Biosensors based on GFP-fusion proteins are powerful
tools for observing real-time events within living cells.
Insertion of GFP within another protein has produced
biosensors capable of signaling intracellular events
through intrinsic fluorescence changes [1,2], fluorescence
resonance energy transfer (FRET) [3,4], and changes in
sub-cellular localization [5]. The difficult task of finding
the right insertion site to produce a biosensor can be accel-
erated by screening libraries of random GFP insertions [6-
8]. The insertional strategies described to date, however,
are limited in two ways. First, each insertion produces
only one kind, or color, of fluorescent fusion protein. Cre-
ating the multicolored libraries necessary for co-expres-
sion or FRET analyses requires either separate rounds of
insertion and screening for each fluorescent protein or
additional subcloning to exchange fluorophores. Second,
the efficiency of any random approach is limited to a max-
imum of 1:6 because a fusion protein can only be pro-
duced if the GFP coding sequence lands in the correct
orientation and reading frame with respect to the target
coding sequence. We reasoned that it might be possible to
overcome these limitations by placing two different fluo-
rescent protein coding sequences in a single transposon,
either in tandem or antiparallel. Here we present the
results of our initial tests with these designs.
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Results and Discussion
The mosaic ends (MEs) that define the hyperactive Tn5
transposon [9] have two possible open reading frames
(ORFs) through them. We used one of these reading
frames to construct the Either-Or transposon (<EYOR>,
Figure 1A). <EYOR> carries the sequence encoding the yel-
low fluorescent protein (YFP) at its 5' end, flanked by two
8 bp restriction sites (Asc I – 5' and Srf I – 3'). An identical
cassette encoding cyan fluorescent protein (CFP) flanked
with Asc I and Srf I sites, is positioned in the same orien-
tation at the 3' end of the transposon. Tn5 transposition,
in vitro, is only ~1% efficient [10], so the kanamycin resist-
ance gene (KanR) was incorporated between the two fluo-
rescent protein cassettes. Since the YFP sequence has no
start codon, it should only be translated if it inserts within
another protein coding sequence in the correct orienta-
tion and reading frame. Plasmids with transposon inser-
tions that are in-frame with respect to the target coding
sequence can be rapidly identified by screening for YFP
fluorescence in transiently transfected mammalian cells.
Each of these clones produces a truncated fusion protein
with YFP at the C-terminus. A stop codon is positioned
downstream of the Srf I site to prevent translation beyond
the YFP coding sequence. These truncated fusion proteins
may provide additional information about which parts of
the primary sequence contain trafficking signals. Full-
length YFP and CFP fusion proteins are then generated in
parallel from each clone by digestion with Srf I or Asc I
and re-ligation. By producing identical full-length YFP
and CFP fusion proteins from each in-frame insertion
<EYOR> should double the efficiency with which multi-
colored fusion protein libraries can be generated.
To test the <EYOR> transposon we targeted Prestin, an
integral membrane protein expressed in outer hair cells of
the cochlea and believed to be the motor responsible for
their rapid changes in length in response to fluctuations in
membrane voltage [11]. The 2.2 kb cDNA encoding Pres-
tin was expressed in a 4.8 kb Ampicillin resistant (AmpR)
CMV expression plasmid, pBNJ12.5. Transposon inser-
tions that disrupt the plasmid origin or AmpR (together
~1.5 kb) are not recovered [8], so the predicted number of
in-frame insertions in Prestin, is ~7%. After transposition,
plasmids conferring AmpR  and KanR  were isolated by
standard mini-prep procedures and transiently expressed
in HEK-293 cells in a 96-well format. In a random sample
of 192 transposed clones, 32 produced detectable fluores-
cence. Eighteen of these (~9%) were clearly localized to
intracellular membranes. (Figure 2A). Of the remaining
fluorescent proteins 11 appeared to be YFP alone, with
evenly distributed fluorescence throughout the entire cell,
and 3 were too dim to determine any sub-cellular locali-
zation. Sequencing revealed that the 18 proteins targeted
to intracellular membranes were truncated Prestin-YFP
fusion proteins resulting from in-frame insertions at 12
unique sites (Figure 2D). One of the YFP-like clones was
an in-frame insertion in the intracellular N-terminus of
Prestin (at amino acids 28–30) upstream of the first pre-
dicted transmembrane domain. The remaining 13 fluores-
cent proteins resulted from <EYOR> insertions outside
the Prestin coding sequence, most of them being clustered
just downstream of the CMV promoter. We could not
identify an in-frame start codon (AUG) in any of these
clones. There is however, an in-frame CUG codon at the 5'
end of the Tn5 ME sequence that may present an alternate
translation initiation site in the presence of the strong
CMV promoter [12].
To verify that <EYOR> could be used to generate full-
length fusions with either YFP or CFP unique in-frame
clones were digested in parallel with Srf I or Asc I and re-
ligated. The resulting fusion constructs were transiently
expressed in HEK-293 cells and screened for YFP and CFP
fluorescence (Figure 2B,2C). All 13 unique insertion sites
produced fluorescent full-length fusions with both CFP
and YFP and all were localized to intracellular
membranes.
The <EYOR> design could be expanded for a wide range
of protein tagging applications by replacing the secondary
CFP cassette with another open reading frame. With such
a transposon, YFP fluorescence would be used as a
reporter to rapidly identify random in-frame insertions.
Subsequent digestion with Asc I and re-ligation could then
generate fusion proteins that might otherwise be difficult
to screen for such as epitope tags, protease cleavage sites,
or even a new N-terminus complete with a secretory signal
peptide. Several groups have reported similar strategies
based on multi-domain transposons for the random
insertion of small peptide tags [reviewed in:[13]]. Like
<EYOR>, these transposons utilize a primary reporter
domain to identify in-frame insertions. Subsequent exci-
sion of the reporter domain (and selectable marker) then
restores the full-length target coding sequence with an
inserted peptide tag. The <EYOR> design is unique, how-
ever, in that its overlapping pairs of Asc I and Srf I restric-
tion sites, allow the user to create identical full-length
fusion proteins from both the reporter domain and the
secondary coding sequence.
The second transposon design, the Double-Barrel transpo-
son (<DBT>, Figure 1B), encodes green and red fluores-
cent proteins (GFP and DsRed) in opposite orientations.
This means that any <DBT> insertion within another pro-
tein coding sequence has a 1:3 chance of being in-frame
regardless of its orientation. Therefore, <DBT> should
double the efficiency of random fusion protein genera-
tion, by producing equal numbers of GFP and DsRed
fusions.BMC Biotechnology 2004, 4:17 http://www.biomedcentral.com/1472-6750/4/17
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In addition to their antiparallel orientation, the GFP and
DsRed coding sequences in <DBT> each use a different rel-
ative reading frame through the Tn5 MEs. As in <EYOR>,
GFP fusion proteins are created by insertions after the
third nucleotide of a target codon. The DsRed  coding
sequence, however, has been shifted by 1 nucleotide rela-
tive to the Tn5 MEs. Therefore, DsRed fusion proteins are
generated by transposon insertions between the second
and third nucleotides. Using different reading frames for
GFP and DsRed doubles the total number of insertion sites
in the target coding sequence from which fusion proteins
could potentially be made. While this does not alter the
frequency of in-frame insertions, it does reduce the screen-
ing cost of saturating a target clone by increasing the prob-
ability of recovering unique in-frame insertions.
To test the efficiency of fusion protein generation with the
<DBT> transposon, we targeted pCMVI-9, a CMV expres-
sion plasmid carrying cDNA encoding the type 1 IP3
receptor (IP3R) [14]. The IP3R is a ligand gated Ca2+ chan-
Two new transposons for generating multicolored GFP fusion protein libraries Figure 1
Two new transposons for generating multicolored GFP fusion protein libraries. In-frame insertions of the Either-
Or transposon, <EYOR> (A), within another coding sequence initially create truncated C-terminal YFP fusions. Alternate 
restriction digestion with Asc I or Srf I removes one of the fluorescent proteins and the KanR. Subsequent re-ligation produces 
identical full-length YFP and CFP fusion proteins. The fluorescent protein is flanked by 9 amino acid linkers encoded by the Tn5 
MEs and restriction sites. The Double Barrel transposon, <DBT> (B), encodes green and red fluorescent proteins (GFP and 
DsRed) antiparallel to one another. Therefore, <DBT> insertions with another coding sequence have a 1:3 chance of being in-
frame regardless of orientation. The GFP coding sequence uses the same reading frame through the Tn5 MEs as YFP in 
<EYOR>. DsRed however, has been shifted by 1 bp to use a different reading frame through the Tn5 MEs, doubling the number 
of usable insertion sites within a target coding sequence (Note that the reading frame shown in <DBT> is that used 
for DsRed, translated from the lower DNA strand, and is read from right to left).BMC Biotechnology 2004, 4:17 http://www.biomedcentral.com/1472-6750/4/17
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nel, composed of 4 homomeric subunits, expressed
within the membranes of the endoplasmic reticulum.
Each IP3R subunit is over 2700 amino acids, and creating
a full-length fluorescent IP3R fusion protein with such a
large cDNA presents a formidable challenge for tradi-
tional molecular biological techniques. The high ratio of
coding sequence to vector makes it an excellent target for
transposition, however, with a predicted frequency of in-
frame insertions of ~11% per fluorophore for <DBT>. At
24 hrs post-transfection, visual screening for fluorescence
of 288 AmpR + KanR clones in HEK-293 cells identified 44
clones that produced green fluorescent proteins. Of these,
35 displayed a uniform cytoplasmic distribution and
exclusion from the nucleus (Figure 3A), 3 showed fluores-
cence throughout the entire cell and 6 were too dim to
determine any sub-cellular localization. Screening at sev-
eral time points between 2 and 4 days post-transfection
identified 7 clones producing red fluorescent proteins, 2
of which were clearly excluded from the nucleus (Figure
3B). The remaining 5 red proteins were too dim to deter-
mine any sub-cellular localization. Sequencing out of the
transposon confirmed that 41 of the clones encoding
green proteins (~14%) and 2 clones encoding red proteins
represented in-frame insertions. Consistent with the
In-frame <EYOR> transposition events in the voltage sensi- tive integral membrane motor protein, Prestin Figure 2
In-frame <EYOR> transposition events in the voltage 
sensitive integral membrane motor protein, Prestin. 
Visual screening of transiently transfected HEK-293 cells 
revealed truncated Prestin-YFP fusion proteins generated by 
in-frame <EYOR> transpositions (A) (scale bar = 20 µm). 
Alternate digestion and re-ligation of an in-frame clone with 
either Srf I or Asc I produces identical full-length YFP- (B) and 
CFP-fusion proteins (C). In-frame <EYOR> insertions in 
Prestin are identified by the first of 3 target amino acids 
duplicated during transposition (D). Redundant insertions are 
indicated by the number of recovered clones (e.g. 3x).
Transposition of the type 1 IP3R with the Double Barrel  Transposon (<DBT>) Figure 3
Transposition of the type 1 IP3R with the Double 
Barrel Transposon (<DBT>). Transient expression in 
HEK-293 cells allows identification of in-frame insertions 
producing truncated GFP- (A) or DsRed- (B) IP3R fusion pro-
teins. Digestion and subsequent re-ligation produces a full-
length fluorescent IP3R fusion protein (C) (Scale bar = 20 
µm).BMC Biotechnology 2004, 4:17 http://www.biomedcentral.com/1472-6750/4/17
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results of the Prestin transposition, all of the proteins with
sub-cellular localization different from that seen with GFP
alone were the product of in-frame insertions. After diges-
tion and religation, only 20 of the full-length fusion pro-
teins retained detectable levels of fluorescence (18 green,
2 red). These full-length proteins displayed a dramatic
shift in their distribution, with clear ER localization (Fig-
ure 3C).
We chose GFP and DsRed to build the <DBT> transposon
because their coding sequences are so dissimilar. Our con-
cern was that if we chose two similar sequences, CFP and
YFP for example, the antiparallel orientation of these cod-
ing sequences could produce extensive mRNA hybridiza-
tion and secondary structure that would inhibit protein
translation. It appears however, that DsRed is not well
suited for insertion within other proteins. Indeed, DsRed
has not been reported as a fusion protein in the middle of
another protein, and even N- and C-terminal fusions with
DsRed can be problematic [15], perhaps due to its being
an obligate multimer [16]. Despite the low yield of DsRed
fusions, these results demonstrate that <DBT> can be used
to simultaneously generate full-length fusion proteins in
two different reading frames. As novel fluorescent pro-
teins are isolated from new species, or old ones are
altered, this type of bi-directional transposon could
potentially double the output of the screening process.
Conclusions
The transposons described here should greatly accelerate
the creation of multicolored libraries of fluorescent fusion
proteins. By creating identical full-length YFP and CFP
fusion proteins from each in-frame insertion, the <EYOR>
transposon not only facilitates the generation potential
FRET pairs, it enables the direct comparison of different
fluorophores in otherwise identical fusion proteins. The
<DBT> design, on the other hand, has the capacity to dou-
ble both the throughput of fusion protein generation by
virtue of its bi-directionality as well as the total output of
novel fusion proteins through the simultaneous use of
multiple reading frames. Ultimately, the ability to gener-
ate large numbers of novel fusions proteins in days rather
than months, should shift the limiting rate at which novel
fluorescent protein biosensors are identified to functional
screening rather than protein design and construction.
Methods
Plasmids
PCR and standard subcloning procedures were used to
create the plasmids encoding <EYOR> (pBNJ55b.1),
<DBT> (pBNJ38.5) and Prestin (pBNJ12.5) (full
sequences in supplementary material). The fluorescent
protein coding sequences used were Venus (YFP) [17],
ECFP-N164H (CFP), EGFP (GFP) and DsRed2 (Clon-
tech). The KanR gene was obtained from pUniV5-His-
TOPO (Invitrogen). The construction of the IP3 receptor
expression plasmid, pCMVI-9, was previously described
[14].
Tn5 transposition and plasmid isolation
Transposons were amplified from their host plasmids via
PCR with a single primer complementary to the 19 bp Tn5
ME (5'-CTGTCTCTTATACACATCT-3') and purified as pre-
viously described [8]. Purified transposon and target con-
centrations were each quantified against an independent
DNA standard using a DynaQuant 200 fluorimeter. The
transposition reaction was performed according to manu-
facturer's recommendations (Epicentre Technologies,
Madison, WI) with 200 ng of target DNA and a molar
equivalent of purified transposon. Electrocompetent XL-
10 Gold E. coli (Stratagene, La Jolla, CA) were transformed
with 0.5 µL of the transposition reaction and plated on LB
agar with Ampicillin (100 µg/mL) and Kanamycin (50 µg/
mL). Parallel plating of the transformation on LB agar
with Ampicillin alone was used to establish the transposi-
tion efficiency.
Transposed plasmids were isolated in a 96-well format
from 1.25 mL LB cultures with Eppendorf PerfectPREP-96
Vac Direct Bind miniprep kits on a PerkinElmer Multi-
PROBE II HT liquid handling robot and eluted in 70 µL of
ddH2O.
Visual screening
HEK-293 cells (American Type Culture Collection CRL-
1573) were plated 24 hr prior to transfection, in 96-well
glass bottom tissue culture plates (NalgeNUNC) at 6 × 104
cells in 100 µL of MEM-E with 10% fetal bovine serum.
Transfections were performed with ~300 ng of plasmid
DNA and 0.3 µL of Lipofectamine 2000™ (Gibco BRL) in
a total volume of 50 µL of Opti-MEMI (Gibco BRL) per
well. The cells were screened for fluorescence 24 hr after
transfection with a 20× objective on a Zeiss inverted
microscope with excitation and emission filter sets opti-
mized for CFP/YFP or GFP/DsRed imaging (Omega, Brat-
tleboro, VT).
Sequencing and generation of full-length fusion proteins
Exact insertion sites were identified for all fluorescent
transposed clones by sequencing 5' out of the transposon
with a primer complimentary to the <EYOR>YFP coding
region (5'-CTGCAGGCCGTAGCC-3') or <DBT>GFP cod-
ing region (5'-TGGCCGTTTACGTCGCCGTCCA-3'). To
generate full-length fusion proteins, plasmids with
unique in-frame insertions were digested and re-ligated.
After restriction digestion (100 ng of plasmid DNA and
0.5 U of Asc I or Srf I in 10 µL total volume), 1 µL of the
digest reaction (~20 ng DNA) was re-ligated with Fast-
Link™ ligase (Epicentre Technologies) for 15 min at room
temperature (0.5 mM ATP, 1X Fast-Link™ buffer, 1 UBMC Biotechnology 2004, 4:17 http://www.biomedcentral.com/1472-6750/4/17
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ligase, 7.5 µL total volume). After heat inactivation (70°C
for 15 min.), XL-10 Gold E. coli were transformed with 0.5
µL of the ligation reaction and plated on LB agar with
Ampicillin. The following day, colonies were co-inocu-
lated in LB with Ampicillin and Ampicillin + Kanamycin
to verify loss of the KanR prior to plasmid isolation.
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